These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 2973893)
21. [Effects of ribavirin on coagulation-anticoagulation in patients with epidemic hemorrhagic fever]. Wang XJ Zhonghua Yi Xue Za Zhi; 1988 Dec; 68(12):699-701. PubMed ID: 2907864 [No Abstract] [Full Text] [Related]
22. Phase II trial of tiazofurin in recurrent squamous cell carcinoma of the head and neck. Dimery IW; Neidhart JA; McCarthy K; Krakoff IH; Hong WK Cancer Treat Rep; 1987 Apr; 71(4):425-6. PubMed ID: 3548960 [No Abstract] [Full Text] [Related]
23. Ribavirin aerosol treatment of bronchiolitis associated with respiratory syncytial virus infection in infants. Taber LH; Knight V; Gilbert BE; McClung HW; Wilson SZ; Norton HJ; Thurson JM; Gordon WH; Atmar RL; Schlaudt WR Pediatrics; 1983 Nov; 72(5):613-8. PubMed ID: 6356005 [TBL] [Abstract][Full Text] [Related]
29. Treatment of influenza A (H1N1) virus infection with ribavirin aerosol. Wilson SZ; Gilbert BE; Quarles JM; Knight V; McClung HW; Moore RV; Couch RB Antimicrob Agents Chemother; 1984 Aug; 26(2):200-3. PubMed ID: 6486761 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of ribavirin in the treatment of acute hepatitis. Patki SA; Gupta P Chemotherapy; 1982; 28(4):298-303. PubMed ID: 6749447 [TBL] [Abstract][Full Text] [Related]
31. Phase II study of tiazofurin in colorectal cancer: a National Cancer Institute of Canada Study. Maroun JA; Eisenhauer E; Cripps C; Maksymiuk A Cancer Treat Rep; 1987 Dec; 71(12):1297-8. PubMed ID: 3690542 [No Abstract] [Full Text] [Related]
33. Efficacy and safety of zanamivir in patients with influenza--impact of age, severity of infections and specific risk factors. Höffken G; Gillissen A Med Microbiol Immunol; 2002 Dec; 191(3-4):169-73. PubMed ID: 12458354 [TBL] [Abstract][Full Text] [Related]
34. Ribavirin: indications for use in pediatrics. Infectious Diseases and Immunization Committee, Canadian Paediatric Society. CMAJ; 1986 Dec; 135(12):1351-2. PubMed ID: 3779570 [No Abstract] [Full Text] [Related]
35. [Ribavirin as an antiviral agent: chemistry, molecular mechanism of action and possibilities of use (review)]. Galegov GA; L'vov ND; Petrova IG; Florent'ev VL Vopr Med Khim; 1986; 32(1):10-9. PubMed ID: 3513441 [No Abstract] [Full Text] [Related]
36. Clinical experiences using the antiviral 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin) in Mexico. Zertuche HF; Perches RD Ann N Y Acad Sci; 1977 Mar; 284():284-8. PubMed ID: 360903 [TBL] [Abstract][Full Text] [Related]
37. Double-blind clinical assessment of ribavirin (virazole) in the prevention of induced infection with type B influenza virus. Togo Y; McCracken EA J Infect Dis; 1976 Jun; 133 Suppl():A109-13. PubMed ID: 778306 [TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of inhaled zanamivir in the prevention of influenza in community-dwelling, high-risk adult and adolescent subjects: a 28-day, multicenter, randomized, double-blind, placebo-controlled trial. LaForce C; Man CY; Henderson FW; McElhaney JE; Hampel FC; Bettis R; Kudule L; Harris J; Yates P; Tisdale M; Webster A Clin Ther; 2007 Aug; 29(8):1579-90; discussion 1577-8. PubMed ID: 17919541 [TBL] [Abstract][Full Text] [Related]